Comment on: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”
Year of publication: |
2014
|
---|---|
Authors: | Gandjour, Afschin |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 32.2014, 12, p. 1245-1246
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic
Gandjour, Afschin, (2021)
-
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin, (2020)
-
Shaikh, Mujaheed, (2018)
- More ...